13-azaprostanoic acid has been researched along with arachidonic acid in 11 studies
Studies (13-azaprostanoic acid) | Trials (13-azaprostanoic acid) | Recent Studies (post-2010) (13-azaprostanoic acid) | Studies (arachidonic acid) | Trials (arachidonic acid) | Recent Studies (post-2010) (arachidonic acid) |
---|---|---|---|---|---|
42 | 0 | 0 | 19,295 | 486 | 3,040 |
Protein | Taxonomy | 13-azaprostanoic acid (IC50) | arachidonic acid (IC50) |
---|---|---|---|
60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 4.5 | |
Fatty acid-binding protein, adipocyte | Homo sapiens (human) | 2.75 | |
10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 4.5 | |
60 kDa chaperonin | Escherichia coli | 7.3 | |
10 kDa chaperonin | Escherichia coli | 7.3 | |
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.0715 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.6026 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (90.91) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brace, LD; Le Breton, GC; Venton, DL | 2 |
Doran, J; Fitzgerald, DJ; FitzGerald, GA; Jackson, E | 1 |
Cassina, G; Livio, M; Macconi, D; Morelli, C; Morzenti, G; Remuzzi, G | 1 |
Bertelé, V; Castagnoli, MN; Cerletti, C; de Gaetano, G; Rajtar, G | 1 |
Ghali, NI; Hung, SC; Kattelman, EJ; Le Breton, GC; Schnorf, KE; Venton, DL | 1 |
Le Breton, GC; Parise, LV; Venton, DL | 1 |
Feinberg, H; Ho, T; Le Breton, GC; Lipowski, JP; Venton, DL; Wu, KK | 1 |
Hall, ER; Papp, A; Wu, KK | 1 |
Colwell, JA; Goldberg, AK; Halushka, PV; Loadholt, CB; Mayfield, R; McCoy, SA; Rogers, RC; Wohltmann, HJ | 1 |
Casonato, A; Deana, R; Francesconi, M; Girolami, A; Scapin, M | 1 |
1 review(s) available for 13-azaprostanoic acid and arachidonic acid
Article | Year |
---|---|
Modulation of vascular thrombosis by products of arachidonic acid metabolism.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Chromatography, Gel; Epoprostenol; Humans; Imidazoles; In Vitro Techniques; Prostanoic Acids; Serum Albumin; Thrombophlebitis; Thromboxane A2; Thromboxane-A Synthase | 1984 |
10 other study(ies) available for 13-azaprostanoic acid and arachidonic acid
Article | Year |
---|---|
Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcium; Chlortetracycline; Cyclic AMP; Epoprostenol; Humans; Ion Channels; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Stimulation, Chemical; Thromboxane A2; Thromboxanes | 1985 |
Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Arterial Occlusive Diseases; Bridged Bicyclo Compounds, Heterocyclic; Coronary Vessels; Dibenzothiepins; Dogs; Fatty Acids, Unsaturated; Hydrazines; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Aggregation; Prostaglandin Endoperoxides; Prostanoic Acids; Rats; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2 | 1986 |
Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Catechols; Chromatography, Thin Layer; Cyclooxygenase Inhibitors; Humans; Imidazoles; In Vitro Techniques; Lipoxygenase Inhibitors; Masoprocol; Phospholipases; Platelet Activating Factor; Platelet Aggregation; Prostanoic Acids; Quinacrine; Radioimmunoassay; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxane-A Synthase | 1985 |
Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Dinoprost; Dinoprostone; Drug Synergism; Humans; Imidazoles; Oxidoreductases; Platelet Aggregation; Prostaglandin D2; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Prostaglandins D; Prostaglandins E; Prostaglandins F; Prostanoic Acids; Thromboxane B2; Thromboxane-A Synthase | 1985 |
Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcium; Chlortetracycline; Epoprostenol; Humans; Indomethacin; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Stimulation, Chemical; Thromboxane A2; Thromboxanes | 1985 |
Synthesis of [17,18-3H] trans-13-azaprostanoic acid. A labeled probe for the PGH2/TXA2 receptor.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Arachidonic Acids; Fatty Acids; Humans; In Vitro Techniques; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostanoic Acids; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Structure-Activity Relationship | 1984 |
Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Arachidonic Acid; Arachidonic Acids; Drug Interactions; Humans; In Vitro Techniques; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxanes | 1984 |
Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Fatty Acids; Male; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Rabbits; Thrombosis; Thromboxane A2; Thromboxanes | 1984 |
Increased platelet arachidonic acid metabolism in diabetes mellitus.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Glucose; Blood Platelets; Diabetes Mellitus; Epinephrine; Humans; Kinetics; Platelet Aggregation; Prostanoic Acids; Thromboxane B2 | 1981 |
Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-Antagonists; Arachidonic Acid; Aspirin; Blood Platelets; Calcium; Drug Synergism; Epinephrine; Humans; Kinetics; Lipoxygenase; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Prostanoic Acids; Serotonin; Sympathomimetics; Thromboxanes; Tyrosine; Vasoconstrictor Agents; von Willebrand Factor; Yohimbine | 2000 |